Koob George F, Vendruscolo Leandro F
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA; Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Stress and Addiction Neuroscience Unit, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, and National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Baltimore, MD, USA.
Alcohol. 2025 Aug 27;129:1-13. doi: 10.1016/j.alcohol.2025.08.004.
Alcohol use disorder is a chronically relapsing disorder that is characterized by compulsive drug seeking and is hypothesized to result from multiple sources of motivational dysregulation in a three-stage cycle of addiction (incentive salience/pathological habits, withdrawal/negative affect, and preoccupation/anticipation). One major source of motivation in the withdrawal/negative affect stage is the physical pain and emotional pain of withdrawal and protracted withdrawal that drive pronounced drug-seeking behavior via the process of negative reinforcement. The construct of negative reinforcement is defined as alcohol taking to alleviate both physical pain and emotional pain (hyperkatifeia) that are created by alcohol abstinence following excessive alcohol consumption. Hyperkatifeia (derived from the Greek "katifeia" for dejection or negative emotional state) is defined as an increase in intensity of the constellation of negative emotional or motivational signs and symptoms of withdrawal from drugs of addiction. In humans and animal models, the repeated misuse of alcohol results in hyperalgesia and hyperkatifeia and is reflected by elevations of reward thresholds, lower pain thresholds, and anxiety- and dysphoric-like responses during alcohol withdrawal. Such symptoms are hypothesized to derive from molecular and neurocircuitry neuroadaptations within the reward system and brain stress systems (e.g., corticotropin-releasing factor, dynorphin, norepinephrine, hypocretin, vasopressin, glucocorticoids, and neuroimmune factors) and brain anti-stress systems (e.g., neuropeptide Y, endocannabinoids, and oxytocin) in the extended amygdala. Thus, our hypothesis is that alcohol withdrawal-induced hyperalgesia and hyperkatifeia persist into protracted withdrawal and contribute to the development and persistence of compulsive alcohol seeking. A conceptual framework for the intersection of physical and emotional pain in addiction is elaborated in the Catastrophizing, Anxiety, Negative Urgency, and Expectancy (CANUE) model, and a significant overlap of brain circuits that mediate emotional pain and physical pain involves the extended amygdala. The intersection of emotional and physical pain reinforces even more dramatically the role of negative reinforcement in alcohol addiction and fits a framework of allostasis (defined as stability with change) where other allostatic loads (defined as the cost of breaks with homeostasis on the body), such as genetics/epigenetics, childhood trauma, and other stressors, exacerbate hyperalgesia/hyperkatifeia in driving alcohol use disorder. The focus on treating hyperalgesia/hyperkatifeia that is associated with acute and protracted withdrawal opens new and exciting avenues for understanding the etiology of alcohol use disorder.
酒精使用障碍是一种慢性复发性疾病,其特征为强迫性觅药行为,据推测是由成瘾三阶段循环中多种动机失调源导致的(动机凸显/病理习惯、戒断/负面情绪以及专注/期待)。戒断/负面情绪阶段的一个主要动机源是戒断及长期戒断带来的身体疼痛和情感痛苦,这些痛苦通过负强化过程驱使显著的觅药行为。负强化的概念被定义为通过饮酒来缓解因过量饮酒后戒酒所产生的身体疼痛和情感痛苦(情绪低落)。情绪低落(源自希腊语“katifeia”,意为沮丧或负面情绪状态)被定义为成瘾药物戒断时负面情绪或动机性体征和症状的强度增加。在人类和动物模型中,反复滥用酒精会导致痛觉过敏和情绪低落,并表现为奖励阈值升高、疼痛阈值降低以及戒酒期间出现焦虑和烦躁样反应。据推测,这些症状源于奖赏系统和脑应激系统(如促肾上腺皮质激素释放因子、强啡肽、去甲肾上腺素、下丘脑泌素、血管加压素、糖皮质激素和神经免疫因子)以及杏仁核扩展区的脑抗应激系统(如神经肽Y、内源性大麻素和催产素)内的分子和神经回路神经适应性变化。因此,我们的假设是,酒精戒断引起的痛觉过敏和情绪低落会持续到长期戒断,并导致强迫性觅酒行为的发展和持续。成瘾中身体疼痛和情感痛苦交叉的概念框架在灾难化、焦虑、消极紧迫性和预期(CANUE)模型中得到了阐述,介导情感痛苦和身体疼痛的脑回路存在显著重叠,涉及杏仁核扩展区。情感痛苦和身体疼痛的交叉更加显著地强化了负强化在酒精成瘾中的作用,并符合一种稳态适应框架(定义为随变化而稳定),其中其他稳态负荷(定义为身体打破内稳态的代价),如遗传/表观遗传学、童年创伤和其他应激源,会在驱动酒精使用障碍时加剧痛觉过敏/情绪低落。关注治疗与急性和长期戒断相关的痛觉过敏/情绪低落,为理解酒精使用障碍的病因开辟了新的、令人兴奋的途径。